Nicole has more than 20 years of commercial strategy and leadership experience and has launched several approved products for rare diseases, including HAE. She previously was US Franchise Head of the Hereditary Angioedema team at Takeda Pharmaceuticals where she was responsible for the US launch of the market-leading HAE prophylaxis treatment Takhzyro®. Before Takeda, Nicole held positions of increasing responsibility at Shire Pharmaceuticals in marketing, sales and product strategy across HAE treatments including Cinryze®, Firazyr® and Kalbitor®, as well serving as the Global Product Strategy Lead for Hemophilia.
Most recently, she served as Chief Commercial Officer at Praxis Precision Medicines, where she led commercial strategy and built capabilities to support global launches for both common and rare CNS conditions. Nicole received a BS in Marketing from the Carroll School of Management at Boston College.
